Logo image of TMO

THERMO FISHER SCIENTIFIC INC (TMO) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:TMO - US8835561023 - Common Stock

619.8 USD
-4.85 (-0.78%)
Last: 1/16/2026, 3:55:02 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TMO. TMO was compared to 57 industry peers in the Life Sciences Tools & Services industry. TMO scores excellent on profitability, but there are some minor concerns on its financial health. TMO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • TMO had positive earnings in the past year.
  • TMO had a positive operating cash flow in the past year.
  • TMO had positive earnings in each of the past 5 years.
  • In the past 5 years TMO always reported a positive cash flow from operatings.
TMO Yearly Net Income VS EBIT VS OCF VS FCFTMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • TMO has a Return On Assets of 6.38%. This is amongst the best in the industry. TMO outperforms 84.21% of its industry peers.
  • The Return On Equity of TMO (12.88%) is better than 85.96% of its industry peers.
  • With a decent Return On Invested Capital value of 7.21%, TMO is doing good in the industry, outperforming 77.19% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for TMO is significantly below the industry average of 13.75%.
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROIC 7.21%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)7.48%
ROIC(5y)8.55%
TMO Yearly ROA, ROE, ROICTMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 15.02%, TMO belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
  • TMO's Profit Margin has been stable in the last couple of years.
  • TMO has a better Operating Margin (18.40%) than 82.46% of its industry peers.
  • TMO's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 41.43%, TMO is in line with its industry, outperforming 42.11% of the companies in the same industry.
  • TMO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
TMO Yearly Profit, Operating, Gross MarginsTMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMO is destroying value.
  • TMO has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TMO has been reduced compared to 5 years ago.
  • TMO has a better debt/assets ratio than last year.
TMO Yearly Shares OutstandingTMO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
TMO Yearly Total Debt VS Total AssetsTMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • The Debt to FCF ratio of TMO is 5.84, which is a neutral value as it means it would take TMO, 5.84 years of fcf income to pay off all of its debts.
  • TMO has a Debt to FCF ratio of 5.84. This is in the better half of the industry: TMO outperforms 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that TMO is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.62, TMO is not doing good in the industry: 68.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Altman-Z N/A
ROIC/WACC0.67
WACC10.71%
TMO Yearly LT Debt VS Equity VS FCFTMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • TMO has a Current Ratio of 1.50. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.50, TMO is doing worse than 73.68% of the companies in the same industry.
  • TMO has a Quick Ratio of 1.11. This is a normal value and indicates that TMO is financially healthy and should not expect problems in meeting its short term obligations.
  • TMO has a worse Quick ratio (1.11) than 70.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.11
TMO Yearly Current Assets VS Current LiabilitesTMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

  • TMO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.53%.
  • TMO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.12% yearly.
  • TMO shows a small growth in Revenue. In the last year, the Revenue has grown by 3.22%.
  • TMO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.92% yearly.
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.66% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.65% on average over the next years.
EPS Next Y5.08%
EPS Next 2Y6.65%
EPS Next 3Y7.9%
EPS Next 5Y9.66%
Revenue Next Year3.54%
Revenue Next 2Y4.26%
Revenue Next 3Y4.7%
Revenue Next 5Y4.65%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TMO Yearly Revenue VS EstimatesTMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TMO Yearly EPS VS EstimatesTMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.67 indicates a quite expensive valuation of TMO.
  • Based on the Price/Earnings ratio, TMO is valued a bit cheaper than 77.19% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of TMO to the average of the S&P500 Index (27.54), we can say TMO is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 24.93, TMO is valued on the expensive side.
  • 78.95% of the companies in the same industry are more expensive than TMO, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 24.31. TMO is around the same levels.
Industry RankSector Rank
PE 27.67
Fwd PE 24.93
TMO Price Earnings VS Forward Price EarningsTMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TMO indicates a somewhat cheap valuation: TMO is cheaper than 68.42% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, TMO is valued a bit cheaper than the industry average as 70.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 38.11
EV/EBITDA 24.46
TMO Per share dataTMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TMO does not grow enough to justify the current Price/Earnings ratio.
  • TMO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.44
PEG (5Y)2.28
EPS Next 2Y6.65%
EPS Next 3Y7.9%

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.28%, TMO is not a good candidate for dividend investing.
  • TMO's Dividend Yield is rather good when compared to the industry average which is at 0.09. TMO pays more dividend than 85.96% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.92, TMO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.28%

5.2 History

  • On average, the dividend of TMO grows each year by 15.42%, which is quite nice.
  • TMO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • TMO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.42%
Div Incr Years7
Div Non Decr Years12
TMO Yearly Dividends per shareTMO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 9.48% of the earnings are spent on dividend by TMO. This is a low number and sustainable payout ratio.
  • TMO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.48%
EPS Next 2Y6.65%
EPS Next 3Y7.9%
TMO Yearly Income VS Free CF VS DividendTMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
TMO Dividend Payout.TMO Dividend Payout, showing the Payout Ratio.TMO Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

NYSE:TMO (1/16/2026, 3:55:02 PM)

619.8

-4.85 (-0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22
Earnings (Next)01-29
Inst Owners92.78%
Inst Owner Change-0.14%
Ins Owners0.1%
Ins Owner Change4.79%
Market Cap232.87B
Revenue(TTM)43.74B
Net Income(TTM)6.57B
Analysts83.13
Price Target646.25 (4.27%)
Short Float %1.36%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 0.28%
Yearly Dividend1.52
Dividend Growth(5Y)15.42%
DP9.48%
Div Incr Years7
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.99%
Min EPS beat(2)1.61%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.9%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)2.24%
EPS beat(12)7
Avg EPS beat(12)1.19%
EPS beat(16)11
Avg EPS beat(16)4.2%
Revenue beat(2)2
Avg Revenue beat(2)0.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)0.47%
Min Revenue beat(4)0.04%
Max Revenue beat(4)0.95%
Revenue beat(8)6
Avg Revenue beat(8)0.12%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)11
Avg Revenue beat(16)2.75%
PT rev (1m)2.37%
PT rev (3m)14.12%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)-1.03%
EPS NY rev (1m)0.01%
EPS NY rev (3m)1.02%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.76%
Valuation
Industry RankSector Rank
PE 27.67
Fwd PE 24.93
P/S 5.32
P/FCF 38.11
P/OCF 30.44
P/B 4.56
P/tB N/A
EV/EBITDA 24.46
EPS(TTM)22.4
EY3.61%
EPS(NY)24.86
Fwd EY4.01%
FCF(TTM)16.26
FCFY2.62%
OCF(TTM)20.36
OCFY3.29%
SpS116.41
BVpS135.81
TBVpS-38.61
PEG (NY)5.44
PEG (5Y)2.28
Graham Number261.62
Profitability
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROCE 9.13%
ROIC 7.21%
ROICexc 7.52%
ROICexgc 33.37%
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
FCFM 13.97%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)7.48%
ROIC(5y)8.55%
ROICexc(3y)8.22%
ROICexc(5y)9.55%
ROICexgc(3y)40.87%
ROICexgc(5y)46.64%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexgc growth 3Y-8.22%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Debt/EBITDA 2.94
Cap/Depr 55.1%
Cap/Sales 3.52%
Interest Coverage 250
Cash Conversion 70.55%
Profit Quality 93%
Current Ratio 1.5
Quick Ratio 1.11
Altman-Z N/A
F-Score8
WACC10.71%
ROIC/WACC0.67
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
EPS Next Y5.08%
EPS Next 2Y6.65%
EPS Next 3Y7.9%
EPS Next 5Y9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
Revenue Next Year3.54%
Revenue Next 2Y4.26%
Revenue Next 3Y4.7%
Revenue Next 5Y4.65%
EBIT growth 1Y8.68%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year15.31%
EBIT Next 3Y9.32%
EBIT Next 5Y9.16%
FCF growth 1Y-6.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-6.36%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%

THERMO FISHER SCIENTIFIC INC / TMO FAQ

What is the ChartMill fundamental rating of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMO.


What is the valuation status of THERMO FISHER SCIENTIFIC INC (TMO) stock?

ChartMill assigns a valuation rating of 4 / 10 to THERMO FISHER SCIENTIFIC INC (TMO). This can be considered as Fairly Valued.


What is the profitability of TMO stock?

THERMO FISHER SCIENTIFIC INC (TMO) has a profitability rating of 7 / 10.


What is the financial health of THERMO FISHER SCIENTIFIC INC (TMO) stock?

The financial health rating of THERMO FISHER SCIENTIFIC INC (TMO) is 4 / 10.


What is the expected EPS growth for THERMO FISHER SCIENTIFIC INC (TMO) stock?

The Earnings per Share (EPS) of THERMO FISHER SCIENTIFIC INC (TMO) is expected to grow by 5.08% in the next year.